Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREAs an aid in the prevention of reovirus induced tenosynovitis by spray or drinking water administration.
LEARN MOREA powerful first-line, broad-spectrum topical medication administered twice a day for 7 days to treat otitis external in dogs.
LEARN MOREFor the vaccination of healthy chickens against disease caused by Avibacterium paragallinarum (CORYZA).
LEARN MORE